|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5132405A
(en)
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
CA2026147C
(en)
|
1989-10-25 |
2006-02-07 |
Ravi J. Chari |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5061620A
(en)
|
1990-03-30 |
1991-10-29 |
Systemix, Inc. |
Human hematopoietic stem cell
|
|
US5151510A
(en)
|
1990-04-20 |
1992-09-29 |
Applied Biosystems, Inc. |
Method of synethesizing sulfurized oligonucleotide analogs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US6005079A
(en)
|
1992-08-21 |
1999-12-21 |
Vrije Universiteit Brussels |
Immunoglobulins devoid of light chains
|
|
US6765087B1
(en)
|
1992-08-21 |
2004-07-20 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
|
ATE199392T1
(de)
|
1992-12-04 |
2001-03-15 |
Medical Res Council |
Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
|
|
ATE204325T1
(de)
|
1993-04-29 |
2001-09-15 |
Unilever Nv |
Herstellung von antikörpern oder funktionstüchtig gemachten teilen davon, abgeleitet von schweren ketten von immunglobulinen von camelidae
|
|
US5675063A
(en)
|
1995-02-28 |
1997-10-07 |
Loyola University Of Chicago |
Immortalized rabbit hybridoma fusion partner
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US7057017B2
(en)
|
1997-04-16 |
2006-06-06 |
Millennium Pharmaceuticals, Inc. |
Human dickkopf-related protein and nucleic acid molecules and uses therefor
|
|
AU751659B2
(en)
|
1997-05-02 |
2002-08-22 |
Genentech Inc. |
A method for making multispecific antibodies having heteromultimeric and common components
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
US6528624B1
(en)
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
|
ATE369144T1
(de)
|
2000-03-31 |
2007-08-15 |
Gen Hospital Corp |
Verfahren zur steigerung des haarwuchses durch wnt polypeptid
|
|
US7713526B2
(en)
|
2001-05-01 |
2010-05-11 |
The Regents Of The University Of California |
Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
|
|
US20030044409A1
(en)
|
2001-05-01 |
2003-03-06 |
Carson Dennis A. |
Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
|
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
|
US7135174B2
(en)
|
2002-01-07 |
2006-11-14 |
Amgen Fremont, Inc. |
Antibodies directed to PDGFD and uses thereof
|
|
US7662925B2
(en)
|
2002-03-01 |
2010-02-16 |
Xencor, Inc. |
Optimized Fc variants and methods for their generation
|
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
|
SI1523496T1
(sl)
*
|
2002-07-18 |
2011-11-30 |
Merus B V |
Rekombinantno proizvajanje zmesi protiteles
|
|
US7960512B2
(en)
|
2003-01-09 |
2011-06-14 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
|
WO2004063351A2
(en)
|
2003-01-09 |
2004-07-29 |
Macrogenics, Inc. |
IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME
|
|
US8367822B2
(en)
|
2003-09-22 |
2013-02-05 |
Enzo Therapeutics, Inc. |
Compositions and methods for bone formation and remodeling
|
|
US9046537B2
(en)
|
2003-09-22 |
2015-06-02 |
Enzo Biochem, Inc. |
Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain
|
|
US8637506B2
(en)
|
2003-09-22 |
2014-01-28 |
Enzo Biochem, Inc. |
Compositions and methods for bone formation and remodeling
|
|
US8461155B2
(en)
|
2003-09-22 |
2013-06-11 |
University Of Connecticut |
Sclerostin and the inhibition of WNT signaling and bone formation
|
|
WO2005032574A1
(en)
|
2003-10-03 |
2005-04-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulation of gastrointestinal epithelium proliferation through the wnt signaling pathway
|
|
EP2221315A1
(en)
|
2003-12-04 |
2010-08-25 |
Xencor, Inc. |
Methods of generating variant proteins with increased host string content and compositions thereof
|
|
CA2555820C
(en)
|
2004-02-19 |
2016-01-19 |
Genentech, Inc. |
Cdr-repaired antibodies
|
|
CA2566607C
(en)
|
2004-05-13 |
2014-04-15 |
University Of Virginia Patent Foundation |
Use of lacritin in promoting ocular cell survival
|
|
US9052324B2
(en)
|
2004-05-19 |
2015-06-09 |
Enzo Biochem, Inc. |
Compounds and assays for controlling Wnt activity
|
|
US8343922B2
(en)
|
2004-05-19 |
2013-01-01 |
Enzo Biochem, Inc. |
Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
|
|
EP2336177A1
(en)
|
2004-08-04 |
2011-06-22 |
Amgen, Inc |
Antibodies to DKK-1
|
|
PL1776384T3
(pl)
|
2004-08-04 |
2013-10-31 |
Mentrik Biotech Llc |
WARIANTY REGIONÓW Fc
|
|
DE102004050620A1
(de)
|
2004-10-13 |
2006-04-20 |
Eberhard-Karls-Universität Tübingen |
Monoklonaler Antikörper gegen Frizzled-Rezeptoren
|
|
US7462697B2
(en)
|
2004-11-08 |
2008-12-09 |
Epitomics, Inc. |
Methods for antibody engineering
|
|
US7632497B2
(en)
|
2004-11-10 |
2009-12-15 |
Macrogenics, Inc. |
Engineering Fc Antibody regions to confer effector function
|
|
EP1844073A1
(en)
|
2005-01-31 |
2007-10-17 |
Ablynx N.V. |
Method for generating variable domain sequences of heavy chain antibodies
|
|
AU2006230413B8
(en)
|
2005-03-31 |
2011-01-20 |
Xencor, Inc |
Fc variants with optimized properties
|
|
US7771937B2
(en)
*
|
2005-05-20 |
2010-08-10 |
University Of Washington |
Methods for predicting late onset Alzheimer disease in an individual
|
|
US20090311243A1
(en)
|
2005-05-30 |
2009-12-17 |
Astrazeneca Ab |
Methods for Identifying FZD8 Modulators and the Use of such Modulators for Treating Osteoarthritis
|
|
US7429487B2
(en)
|
2005-07-05 |
2008-09-30 |
Epitomics, Inc. |
Fusion partner for production of monoclonal rabbit antibodies
|
|
DE102005035568A1
(de)
|
2005-07-25 |
2007-02-01 |
M-Phasys Gmbh |
Frizzled 9 als Biomarker für Substrukturen des humanen Gehirns
|
|
KR101866623B1
(ko)
|
2005-11-28 |
2018-07-04 |
젠맵 에이/에스 |
재조합 １가 항체 및 그의 제조 방법
|
|
CA2635906A1
(en)
|
2006-02-07 |
2007-08-16 |
Wyeth |
Materials and methods for identifying agents that modulate norrin. norrin mimetics, and agents identified thereby
|
|
AU2007257692B2
(en)
|
2006-06-12 |
2013-11-14 |
Aptevo Research And Development Llc |
Single-chain multivalent binding proteins with effector function
|
|
KR101351208B1
(ko)
|
2006-06-21 |
2014-01-14 |
온코세라피 사이언스 가부시키가이샤 |
Ｆｚｄ10에 대한 종양-표적화 모노클로날 항체 및 이의 용도
|
|
GB0624500D0
(en)
*
|
2006-12-07 |
2007-01-17 |
Istituto Superiore Di Sanito |
A novel passive vaccine for candida infections
|
|
US7939075B2
(en)
|
2007-01-11 |
2011-05-10 |
Philipps-Universitaet Marburg |
Human monoclonal anti-amyloid-beta antibodies
|
|
WO2008134632A1
(en)
|
2007-04-26 |
2008-11-06 |
President And Fellows Of Harvard College |
Wnt ligands involved in blood-brain barrier development and uses therefor
|
|
EP3305324A1
(en)
*
|
2007-11-02 |
2018-04-11 |
Novartis AG |
Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6)
|
|
WO2009064944A2
(en)
*
|
2007-11-16 |
2009-05-22 |
Nuvelo, Inc. |
Antibodies to lrp6
|
|
US9266967B2
(en)
|
2007-12-21 |
2016-02-23 |
Hoffmann-La Roche, Inc. |
Bivalent, bispecific antibodies
|
|
JP2011516549A
(ja)
|
2008-04-11 |
2011-05-26 |
バイオジェン アイデック マサチューセッツ インコーポレイテッド |
抗ｉｇｆ−１ｒ抗体と他の化合物との治療的併用
|
|
WO2010016766A2
(en)
|
2008-08-08 |
2010-02-11 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Antibodies recognizing endogenous human lgr5 and/or lgr6
|
|
ES2658117T3
(es)
|
2008-08-18 |
2018-03-08 |
Pfizer Inc. |
Anticuerpos anti-CCR2
|
|
SG193209A1
(en)
|
2008-09-10 |
2013-09-30 |
Genentech Inc |
Methods for inhibiting ocular angiogenesis
|
|
AU2009296246B2
(en)
|
2008-09-26 |
2015-07-30 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
|
GB0819449D0
(en)
|
2008-10-23 |
2008-12-03 |
Cambridge Display Tech Ltd |
Display drivers
|
|
DK2356270T3
(da)
|
2008-11-07 |
2016-12-12 |
Fabrus Llc |
Kombinatoriske antistofbiblioteker og anvendelser deraf
|
|
EP2412800A1
(en)
|
2010-07-29 |
2012-02-01 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Liver organoid, uses thereof and culture method for obtaining them
|
|
EP3061808B1
(en)
|
2009-02-03 |
2020-08-12 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Culture medium for epithelial stem cells and organoids comprising said stem cells
|
|
US20100254979A1
(en)
|
2009-03-06 |
2010-10-07 |
Cisthera, Incorporated |
Humanized PAI-1 Antibodies and Uses Thereof
|
|
EP2424567B1
(en)
|
2009-04-27 |
2018-11-21 |
OncoMed Pharmaceuticals, Inc. |
Method for making heteromultimeric molecules
|
|
US9175070B2
(en)
*
|
2009-09-25 |
2015-11-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Neutralizing antibodies to HIV-1 and their use
|
|
WO2011043591A2
(en)
|
2009-10-06 |
2011-04-14 |
Snu R&Db Foundation |
Method for differentiation into retinal cells from stem cells
|
|
NZ600820A
(en)
|
2009-12-29 |
2014-12-24 |
Emergent Product Dev Seattle |
Heterodimer binding proteins and uses thereof
|
|
WO2011088226A2
(en)
|
2010-01-13 |
2011-07-21 |
Caris Life Sciences Luxembourg Holdings |
Detection of gastrointestinal disorders
|
|
AU2011217964B2
(en)
|
2010-02-19 |
2016-07-14 |
The Board Of Regents Of The University Of Oklahoma |
Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof
|
|
EP2550295A1
(en)
|
2010-03-24 |
2013-01-30 |
F. Hoffmann-La Roche AG |
Anti-lrp6 antibodies
|
|
JP2013530929A
(ja)
|
2010-04-01 |
2013-08-01 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
ｆｒｉｚｚｌｅｄ結合剤およびその使用
|
|
WO2011127164A2
(en)
|
2010-04-08 |
2011-10-13 |
Fate Therapeutics, Inc. |
Pharmaceutical compositions to treat fibrosis
|
|
EP2566892B1
(en)
|
2010-05-06 |
2017-12-20 |
Novartis AG |
Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (lrp6) antibodies
|
|
CA2798390A1
(en)
|
2010-05-06 |
2011-11-10 |
Novartis Ag |
Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
|
|
RS59589B1
(sr)
|
2010-11-05 |
2019-12-31 |
Zymeworks Inc |
Dizajniranje stabilnog heterodimernog antitela sa mutacijama u fc domenu
|
|
AU2012211277A1
(en)
|
2011-01-28 |
2013-08-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Wnt compositions and methods of use thereof
|
|
GB201106395D0
(en)
|
2011-04-14 |
2011-06-01 |
Hubrecht Inst |
Compounds
|
|
AU2012295394B2
(en)
|
2011-08-12 |
2016-04-14 |
Omeros Corporation |
Anti-FZD10 monoclonal antibodies and methods for their use
|
|
EP3653222A1
(en)
|
2011-10-14 |
2020-05-20 |
Novartis AG |
Antibodies and methods for wnt pathway-related diseases
|
|
EP3290442A1
(en)
|
2011-11-04 |
2018-03-07 |
Novartis AG |
Low density lipoprotein-related protein 6 (lrp6) half-life extender constructs
|
|
BR112014015018A2
(pt)
|
2011-12-19 |
2020-10-27 |
Synimmune Gmbh |
moléculas de anticorpo biespecífico e seu método de produção, bem como composição farmacêutica e molécula de ácido nucleico
|
|
SG10201601747XA
(en)
|
2012-01-18 |
2016-04-28 |
Genentech Inc |
Anti-LRP5 Antibodies And Methods Of Use
|
|
WO2014029752A1
(en)
|
2012-08-22 |
2014-02-27 |
Glaxo Group Limited |
Anti lrp6 antibodies
|
|
WO2014059068A1
(en)
|
2012-10-11 |
2014-04-17 |
The Trustees Of The University Of Pennsylvania |
Methods for the treatment and prevention of osteoporosis and bone-related disorders
|
|
WO2014059442A2
(en)
*
|
2012-10-12 |
2014-04-17 |
Arizona Board Agents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Antibody based reagents that specifically recognize toxic oligomeric forms of tau
|
|
CN105073195A
(zh)
|
2013-02-04 |
2015-11-18 |
昂科梅德制药有限公司 |
使用Wnt途径抑制剂进行治疗的方法及对该治疗的监测
|
|
WO2014124326A1
(en)
|
2013-02-08 |
2014-08-14 |
Stem Centrx, Inc. |
Novel multispecific constructs
|
|
WO2014130728A1
(en)
|
2013-02-21 |
2014-08-28 |
Van Andel Research Institute |
Norrin mutant polypeptides, methods of making and uses thereof
|
|
US20140255403A1
(en)
|
2013-03-06 |
2014-09-11 |
Hadasit Medical Research Services & Development Ltd. |
Oral composition comprising a tnf antagonist and use thereof
|
|
KR20150130421A
(ko)
|
2013-03-14 |
2015-11-23 |
온코메드 파마슈티칼스, 인크. |
Met-결합제 및 그의 용도
|
|
US9850297B2
(en)
|
2013-03-15 |
2017-12-26 |
Amgen Inc. |
Secreted frizzle-related protein 5 (SFRP5) binding proteins
|
|
JP6283408B2
(ja)
*
|
2013-03-15 |
2018-02-21 |
アムジェン インコーポレイテッド |
ヒトｐａｃ１抗体
|
|
EP3705494A3
(en)
|
2013-08-14 |
2020-12-09 |
Sachdev Sidhu |
Antibodies against frizzled proteins and methods of use thereof
|
|
GB2518221A
(en)
|
2013-09-16 |
2015-03-18 |
Sergej Michailovic Kiprijanov |
Tetravalent antigen-binding protein molecule
|
|
BR112016006502A2
(pt)
|
2013-09-30 |
2017-09-19 |
Chugai Pharmaceutical Co Ltd |
Método para a produção de molécula de ligação de antígeno usando-se fago auxiliar modificado
|
|
GB2519786A
(en)
|
2013-10-30 |
2015-05-06 |
Sergej Michailovic Kiprijanov |
Multivalent antigen-binding protein molecules
|
|
US9629801B2
(en)
*
|
2014-01-10 |
2017-04-25 |
Wisconsin Alumni Research Foundation |
Blood-brain barrier targeting antibodies
|
|
US9209965B2
(en)
|
2014-01-14 |
2015-12-08 |
Microsemi Semiconductor Ulc |
Network interface with clock recovery module on line card
|
|
WO2015109212A1
(en)
|
2014-01-17 |
2015-07-23 |
Pfizer Inc. |
Anti-il-2 antibodies and compositions and uses thereof
|
|
CA2955086A1
(en)
|
2014-08-08 |
2016-02-11 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
|
WO2016037016A1
(en)
|
2014-09-03 |
2016-03-10 |
The Brigham And Women's Hospital, Inc. |
Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss
|
|
EP4219564A1
(en)
|
2014-09-12 |
2023-08-02 |
The Board of Trustees of the Leland Stanford Junior University |
Wnt signaling agonist molecules
|
|
PL3221357T3
(pl)
|
2014-11-20 |
2020-11-02 |
F. Hoffmann-La Roche Ag |
Wspólne łańcuchy lekkie i sposoby zastosowania
|
|
US9777052B2
(en)
|
2014-12-02 |
2017-10-03 |
The Board Of Regents Of The University Of Oklahoma |
R-spondin variants, compositions, and methods of use
|
|
CA2874083C
(en)
*
|
2014-12-05 |
2024-01-02 |
Universite Laval |
Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
|
|
WO2016168607A1
(en)
|
2015-04-15 |
2016-10-20 |
University Of Tennessee Research Foundation |
Compositions and methods of muc13 antibodies for cancer treatment and diagnosis
|
|
US20160312207A1
(en)
|
2015-04-21 |
2016-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
R-spondin antagonists and methods of treating cancer associated with aberrant activation of wnt signaling
|
|
WO2016205566A1
(en)
|
2015-06-16 |
2016-12-22 |
The Regents Of The University Of California |
Fzd7 specific antibodies and vaccines to treat cancer and control stem cell function
|
|
WO2016205551A2
(en)
|
2015-06-16 |
2016-12-22 |
The Regents Of The University Of California |
Fzd7 specific antibodies and vaccines to treat cancer and control stem cell function
|
|
EA039859B1
(ru)
|
2015-07-31 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
|
SG11201803061UA
(en)
|
2015-10-21 |
2018-05-30 |
Univ Indiana Res & Tech Corp |
Methods of generating human inner ear sensory epithelia and sensory neurons
|
|
CA3012720C
(en)
|
2016-01-29 |
2023-01-31 |
The Governing Council Of The University Of Toronto |
Frizzled5 protein-binding agents
|
|
UA126657C2
(uk)
|
2016-02-03 |
2023-01-11 |
Емджен Рісерч (Мюнік) Ґмбг |
ОДНОЛАНЦЮГОВА КОНСТРУКЦІЯ АНТИТІЛА ДО BCMA І CD3<font face="Symbol">e</font>
|
|
AU2017214692B2
(en)
|
2016-02-06 |
2021-11-04 |
Epimab Biotherapeutics, Inc. |
Fabs-in-tandem immunoglobulin and uses thereof
|
|
AU2017227844A1
(en)
|
2016-03-02 |
2018-08-30 |
Frequency Therapeutics, Inc. |
Methods for controlled proliferation of stem cells / generating inner ear hair cells using GSK-3-alpha inhibitors
|
|
WO2017152102A2
(en)
|
2016-03-04 |
2017-09-08 |
Alector Llc |
Anti-trem1 antibodies and methods of use thereof
|
|
US20170349659A1
(en)
|
2016-06-03 |
2017-12-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Wnt signaling agonist molecules
|
|
JP7617603B2
(ja)
|
2017-01-11 |
2025-01-20 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
Ｒ－スポンジン（ｒｓｐｏ）サロゲート分子
|
|
JP7305543B2
(ja)
|
2017-01-26 |
2023-07-10 |
スロゼン オペレーティング， インコーポレイテッド |
組織特異的Ｗｎｔシグナル増強分子およびその使用
|
|
MA48760A
(fr)
|
2017-05-31 |
2020-04-08 |
Boehringer Ingelheim Int |
Polypeptides ayant un effet antagoniste sur la signalisation wnt dans des cellules tumorales
|
|
CN117946267A
(zh)
|
2017-12-19 |
2024-04-30 |
瑟罗泽恩奥普瑞汀公司 |
抗卷曲蛋白抗体和使用方法
|
|
AU2018393073B2
(en)
|
2017-12-19 |
2025-09-18 |
Surrozen Operating, Inc. |
Wnt surrogate molecules and uses thereof
|
|
CA3085785A1
(en)
|
2017-12-19 |
2019-06-27 |
Surrozen, Inc. |
Anti-lrp5/6 antibodies and methods of use
|
|
EP3752537A4
(en)
|
2018-02-14 |
2021-12-01 |
Antlera Therapeutics Inc. |
MULTIVALENT LINK MOLECULES ACTIVATE WNT SIGNALING AND THEIR USES
|
|
AU2019297522A1
(en)
|
2018-07-05 |
2021-01-28 |
Surrozen Operating, Inc. |
Multi-specific Wnt surrogate molecules and uses thereof
|
|
CN112654363A
(zh)
|
2018-07-09 |
2021-04-13 |
瑟罗泽恩公司 |
组织特异性wnt信号增强分子和其用途
|
|
WO2020132356A1
(en)
|
2018-12-19 |
2020-06-25 |
Surrozen, Inc. |
Antigen binding formats for receptor complexes
|
|
EP3924381A4
(en)
|
2019-02-11 |
2023-07-26 |
Surrozen Operating, Inc. |
MODULATION OF WNT SIGNALING IN EYE DISEASES
|
|
JP2022525300A
(ja)
|
2019-03-11 |
2022-05-12 |
スロゼン オペレーティング， インコーポレイテッド |
胃腸障害におけるｗｎｔシグナル伝達の調節
|
|
US20220175884A1
(en)
|
2019-04-02 |
2022-06-09 |
Surrozen Operating, Inc. |
Modulation of wnt signaling in auditory disorders
|
|
US11050604B2
(en)
|
2019-07-01 |
2021-06-29 |
Rampart Communications, Inc. |
Systems, methods and apparatuses for modulation-agnostic unitary braid division multiplexing signal transformation
|
|
AU2020300618A1
(en)
|
2019-07-02 |
2022-01-27 |
Surrozen Operating, Inc. |
Monospecific anti-frizzled antibodies and methods of use
|
|
US20230138045A1
(en)
|
2020-02-24 |
2023-05-04 |
Surrozen Operating, Inc. |
Wnt super agonists
|
|
KR20230109668A
(ko)
|
2020-11-16 |
2023-07-20 |
서로젠 오퍼레이팅, 인크. |
간-특이적 Wnt 신호 증강 분자 및 그의 용도
|
|
JP2024509266A
(ja)
|
2021-03-10 |
2024-02-29 |
スロゼン オペレーティング， インコーポレイテッド |
胃腸障害におけるｗｎｔシグナル伝達のモジュレーション
|
|
EP4401841A4
(en)
|
2021-09-14 |
2025-07-02 |
Surrozen Operating Inc |
MODULATION OF WNT SIGNALING IN PULMONARY DISORDERS
|